Content area
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Details
Title
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance
Author
Verma, Vivek 1 ; Shrimali, Rajeev K 2 ; Ahmad, Shamim 3 ; Dai, Winjie 4 ; Wang, Hua 4 ; Lu, Sumin 4 ; Nandre, Rahul 1 ; Gaur, Pankaj 1 ; Lopez, Jose 5 ; Sade-Feldman, Moshe 6 ; Keren Yizhak 7 ; Bjorgaard, Stacey L 6 ; Flaherty, Keith T 8
; Wargo, Jennifer A 9
; Boland, Genevieve M 10 ; Sullivan, Ryan J 8
; Getz, Gad 11
; Hammond, Scott A 12 ; Tan, Ming 13 ; Qi, Jingjing 14 ; Wong, Phillip 14 ; Taha Merghoub 15
; Wolchok, Jedd 15
; Hacohen, Nir 6
; Janik, John E 16 ; Mkrtichyan, Mikayel 17 ; Gupta, Seema 1 ; Khleif, Samir N 1
1 Georgia Cancer Center, Augusta University, Augusta, GA, USA; The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA
2 Georgia Cancer Center, Augusta University, Augusta, GA, USA; Therapeutic Discovery, MD Anderson Cancer Center, Houston, TX, USA
3 Georgia Cancer Center, Augusta University, Augusta, GA, USA; Five Prime Therapeutics Inc., South San Francisco, CA, USA
4 Georgia Cancer Center, Augusta University, Augusta, GA, USA
5 The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA
6 Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA
7 Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA
8 Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA
9 Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
10 Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
11 Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
12 MedImmune LLC, Gaithersburg, MD, USA
13 Department of Biostatistics, Bioinformatics & Biomathematics, Georgetown University, Washington, DC, USA
14 Memorial Sloan Kettering Cancer Center, New York, NY, USA
15 Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical and Graduate Schools, New York, NY, USA
16 Georgia Cancer Center, Augusta University, Augusta, GA, USA; Incyte Inc., Wilmington, DE, USA
17 Georgia Cancer Center, Augusta University, Augusta, GA, USA; The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA; A2 Biotherapeutics, Agoura Hills, CA, USA
; Wargo, Jennifer A 9
; Boland, Genevieve M 10 ; Sullivan, Ryan J 8
; Getz, Gad 11
; Hammond, Scott A 12 ; Tan, Ming 13 ; Qi, Jingjing 14 ; Wong, Phillip 14 ; Taha Merghoub 15
; Wolchok, Jedd 15
; Hacohen, Nir 6
; Janik, John E 16 ; Mkrtichyan, Mikayel 17 ; Gupta, Seema 1 ; Khleif, Samir N 1
1 Georgia Cancer Center, Augusta University, Augusta, GA, USA; The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA
2 Georgia Cancer Center, Augusta University, Augusta, GA, USA; Therapeutic Discovery, MD Anderson Cancer Center, Houston, TX, USA
3 Georgia Cancer Center, Augusta University, Augusta, GA, USA; Five Prime Therapeutics Inc., South San Francisco, CA, USA
4 Georgia Cancer Center, Augusta University, Augusta, GA, USA
5 The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA
6 Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA
7 Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA
8 Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA
9 Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
10 Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
11 Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
12 MedImmune LLC, Gaithersburg, MD, USA
13 Department of Biostatistics, Bioinformatics & Biomathematics, Georgetown University, Washington, DC, USA
14 Memorial Sloan Kettering Cancer Center, New York, NY, USA
15 Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical and Graduate Schools, New York, NY, USA
16 Georgia Cancer Center, Augusta University, Augusta, GA, USA; Incyte Inc., Wilmington, DE, USA
17 Georgia Cancer Center, Augusta University, Augusta, GA, USA; The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA; A2 Biotherapeutics, Agoura Hills, CA, USA
Pages
1555-1555
Publication year
2019
Publication date
Nov 2019
ISSN
15292908
e-ISSN
15292916
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2309510381
Copyright
Copyright Nature Publishing Group Nov 2019